Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR – Get Free Report) saw a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 1,070,000 shares, a drop of 7.0% from the November 30th total of 1,150,000 shares. Based on an average daily trading volume, of 301,300 shares, the short-interest […]
StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report report published on Tuesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Citigroup lowered their target price on shares of Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating for the company […]
Eiger BioPharmaceuticals (NASDAQ:EIGR) Stock Crosses Below 50-Day Moving Average of $0 30 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, Citigroup lowered their price target on shares of Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating on the […]
StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research note issued to investors on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, Citigroup cut their target price on Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating for the company in […]